Got approval from US-FDA
Ajanta Pharma has launched after due approval from the US FDA Amlodipine + Olmesartan Medoxomil Tablets in the US market through its wholly owned subsidiary Ajanta Pharma USA Inc. Ajanta now has 29 Abbreviated New Drug Application (ANDA) of which it has for 16 final ANDA approvals; 2 tentative approvals; and 11 ANDAs under review with US FDA.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
